Document Detail

Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.
MedLine Citation:
PMID:  21828118     Owner:  NLM     Status:  MEDLINE    
The runt-related transcription factor 1, RUNX1, is crucial in the development of myeloid and lymphoid cell lineages and has been reported to be mutated in myeloid malignancies in approximately 30% of cases. In this study, the mutational status of RUNX1 was investigated in 128 acute lymphoblastic leukemia patients. We detected a mutation rate of 18.3% (13 of 71) in patients with T-cell acute lymphoblastic leukemia, 3.8% (2 of 52) in patients with B-cell acute lymphoblastic leukemia and no mutation (0 of 5) in patients with natural killer cell leukemia, respectively. In T-cell acute lymphoblastic leukemia patients, RUNX1 mutations were significantly associated with higher age (P=0.017) and lower white blood cell count (P=0.038). Moreover, an inferior outcome was observed in the subgroup of early T-cell acute lymphoblastic leukemia patients carrying RUNX1 mutations for overall survival (P=0.043). In conclusion, RUNX1 mutations are an important novel biomarker for a comprehensive characterization of T-cell acute lymphoblastic leukemia with poor prognostic impact and have implications for use also in monitoring disease.
Vera Grossmann; Wolfgang Kern; Stefan Harbich; Tamara Alpermann; Sabine Jeromin; Susanne Schnittger; Claudia Haferlach; Torsten Haferlach; Alexander Kohlmann
Related Documents :
21638088 - Assessment of braf v600e mutation status by immunohistochemistry with a mutation-specif...
22057038 - Pcr for monitoring of minimal residual disease in hematologic malignancy.
9596078 - Mutations in clcn5 chloride channel in japanese patients with low molecular weight prot...
21643018 - Acquisition of p53 mutations in response to the non-genotoxic p53 activator nutlin-3.
1391048 - The spoiin279(ts) mutation affects the ftsa protein of bacillus subtilis.
21129438 - The g-712a polymorphism of brain-derived neurotrophic factor is associated with major d...
Publication Detail:
Type:  Journal Article     Date:  2011-08-09
Journal Detail:
Title:  Haematologica     Volume:  96     ISSN:  1592-8721     ISO Abbreviation:  Haematologica     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-07     Completed Date:  2012-04-04     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  0417435     Medline TA:  Haematologica     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  1874-7     Citation Subset:  IM    
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377 Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Core Binding Factor Alpha 2 Subunit / genetics*
Disease-Free Survival
Genetic Markers
Middle Aged
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*,  mortality*
Survival Rate
Reg. No./Substance:
0/Core Binding Factor Alpha 2 Subunit; 0/Genetic Markers; 0/RUNX1 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of morphokinetics as a predictor of embryo implantation.
Next Document:  Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations ...